These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 22318511)

  • 41. Sleep duration and dietary macronutrient consumption can modify the cardiovascular disease for Korean women but not for men.
    Doo M; Kim Y
    Lipids Health Dis; 2016 Jan; 15():17. PubMed ID: 26819201
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardiovascular disease and hypertension among adults with bipolar I disorder in the United States.
    Goldstein BI; Fagiolini A; Houck P; Kupfer DJ
    Bipolar Disord; 2009 Sep; 11(6):657-62. PubMed ID: 19689508
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of hypertension with depression in the community: results from the Gutenberg Health Study.
    Michal M; Wiltink J; Lackner K; Wild PS; Zwiener I; Blettner M; Münzel T; Schulz A; Kirschner Y; Beutel ME
    J Hypertens; 2013 May; 31(5):893-9. PubMed ID: 23449018
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Doctors' estimation of cardiovascular risk and willingness to give drug treatment in hypertension: fair risk assessment but defensive treatment policy.
    Persson M; Carlberg B; Tavelin B; Lindholm LH
    J Hypertens; 2004 Jan; 22(1):65-71. PubMed ID: 15106796
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Primary prevention of cardiovascular disease in Greece: Greek results of the EURIKA study.
    Elisaf M; Tzouvelekis E; Nikas N;
    Hellenic J Cardiol; 2014; 55(3):217-26. PubMed ID: 24862614
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Do physicians estimate reliably the cardiovascular risk of hypertensive patients?
    Chatellier G; Blinowska A; Menard J; Degoulet P
    Medinfo; 1995; 8 Pt 2():876-9. PubMed ID: 8591574
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Antihypertensive treatment and cardiovascular disorders].
    Rorive GL
    Rev Med Liege; 1983 Jun; 38(12):549-55. PubMed ID: 6612126
    [No Abstract]   [Full Text] [Related]  

  • 48. Dissemination and Implementation Program in Hypertension in Rwanda: Report on Initial Training and Evaluation.
    Baumann AA; Mutabazi V; Brown AL; Hooley C; Reeds D; Ingabire C; Ndahindwa V; Nishimwe A; Cade WT; de las Fuentes L; Proctor EK; Karengera S; Schecthman KB; Goss CW; Yarasheski K; Newsome B; Mutimura E; Davila-Roman VG
    Glob Heart; 2019 Jun; 14(2):135-141. PubMed ID: 31324367
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Utility of Framingham risk score in urban emergency department patients with asymptomatic hypertension.
    Brody AM; Flack JM; Ference BA; Levy PD
    Crit Pathw Cardiol; 2014 Sep; 13(3):114-6. PubMed ID: 25062396
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Spatiotemporal Variation of the Association between Urbanicity and Incident Hypertension among Chinese Adults.
    Wu J; Chen J; Li Z; Jiao B; Muennig P
    Int J Environ Res Public Health; 2020 Jan; 17(1):. PubMed ID: 31906366
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Addressing the diagnostic gap in hypertension through possible interventions and scale-up: A microsimulation study.
    Koeppel L; Dittrich S; Brenner Miguel S; Carmona S; Ongarello S; Vetter B; Cohn JE; Baernighausen T; Geldsetzer P; Denkinger CM;
    PLoS Med; 2022 Dec; 19(12):e1004111. PubMed ID: 36472973
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cancer patients with potential eligibility for vascular endothelial growth factor antagonists use have an increased risk for cardiovascular diseases comorbidities.
    Liu F; Hidru TH; Gao R; Lin Y; Liu Y; Fang F; Liu J; Li H; Yang X; Xia Y
    J Hypertens; 2020 Mar; 38(3):426-433. PubMed ID: 31584518
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Machine Learning Model for Predicting CVD Risk on NHANES Data.
    Klados GA; Politof K; Bei ES; Moirogiorgou K; Anousakis-Vlachochristou N; Matsopoulos GK; Zervakis M
    Annu Int Conf IEEE Eng Med Biol Soc; 2021 Nov; 2021():1749-1752. PubMed ID: 34891625
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Blood pressure and global risk assessment in a Swedish population.
    Eckner J; Larsson CA; Råstam L; Lindblad U
    Int J Hypertens; 2012; 2012():835812. PubMed ID: 22991653
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vascular Disease in Young Indians (20-40 years): Role of Hypertension.
    Dalal J; Sethi KK; Kerkar PG; Ray S; Guha S; Hiremath MS
    J Clin Diagn Res; 2016 Aug; 10(8):OE01-6. PubMed ID: 27656492
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Patients who voluntarily abandon treatment for hypertension. Evolution of their cardiovascular risk in one year].
    Hernández ML; Alemán JA; Jara P; López RL
    Aten Primaria; 2007 Nov; 39(11):621-2. PubMed ID: 18001647
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacologic Treatment for High BP and Risk of CVD.
    Palma JA; Kaufmann H
    JAMA; 2024 Feb; 331(6):530-531. PubMed ID: 38349377
    [No Abstract]   [Full Text] [Related]  

  • 58. Hypertension in diabetes and the risk of cardiovascular disease.
    Sunkara N; H Ahsan C
    Cardiovasc Endocrinol; 2017 Mar; 6(1):33-38. PubMed ID: 31646117
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of fruit and vegetable intake with predicted 10-year cardiovascular disease risk among hypertensive patients in Addis Ababa, Ethiopia: a cross-sectional study.
    Mekonene M; Gebremedhin S; Bikila D; Ashebir G; Baye K
    BMJ Open; 2023 Aug; 13(8):e075893. PubMed ID: 37640463
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mediation of 10-Year Cardiovascular Disease Risk between Inflammatory Diet and Handgrip Strength: Base on NHANES 2011-2014.
    Xie Z; Wang L; Sun M; Wang R; Li J; Wang X; Guo R; Dong Y; Wang Y; Li B
    Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.